JOENJA DIN 02569809
Health Canada record
| Active ingredient(s) | LENIOLISIB (LENIOLISIB PHOSPHATE) 70 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION RECOMMENDED |
| Class | Human |
| ATC | L03AX22 LENIOLISIB |
| Original market date | |
| Current status date | 08-Jul-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37862 | 2026-07-08 | New Drug Submission (NDS) |